Vai al contenuto principale della pagina
Titolo: | Implementing a national cancer clinical trials system for the 21st century : workshop summary / / an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
Pubblicazione: | Washington, D.C., : National Academies Press, 2011 |
Edizione: | 1st ed. |
Descrizione fisica: | 1 online resource (100 p.) |
Disciplina: | 616.994060724 |
Soggetto topico: | Cancer - Treatment - Research |
Clinical trials | |
Altri autori: | MackAlison NassSharyl J |
Note generali: | Description based upon print version of record. |
Nota di bibliografia: | Includes bibliographical references. |
Nota di contenuto: | ""Front matter""; ""Reviewers""; ""Contents""; ""Implementing a National Cancer Clinical Trials System for the 21st Century""; ""References""; ""Acronyms""; ""A Workshop Agenda""; ""B Executive Summary of A National Cancer Clinical Trials System for the 21st Century"" |
Sommario/riassunto: | "Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description. |
Titolo autorizzato: | Implementing a national cancer clinical trials system for the 21st century |
ISBN: | 0-309-21271-5 |
1-283-31188-7 | |
9786613311887 | |
0-309-21269-3 | |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910810598403321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |